Group A (the standard 2HRZE/4HR regimen）
K18-103
Approved small_molecule completed
Quick answer
Group A (the standard 2HRZE/4HR regimen） for Pulmonary Tuberculosis TB in Sputum: (+) Microscopy is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed